Enzyme ImmunoAssay (EIA) is a technique to detect and quantify antigens (proteins, hormones…) or antibodies in samples. It relies on the ability of an antibody to bind a specific antigen. Either the antibody or the antigen is labelled with an enzyme wh...
MoreThis product can not be purchased online. Please contact us
Size | 96 wells |
Shipping | dry ice |
Application Media | Plasma with extraction on C18 SEP Pack 3cc cartridge |
Sample volume | 50 µL |
Tracer | AcetylCholinesterase AChE |
Detection Limit | 0,07 ng/mL |
Standard Curve Range | 0,10-12,50 ng/mL |
Custom Code | 3822000000 |
UNSPSC code | 41116104 |
PRODUCT EXPLANATION: ACETYLCHOLINESTERASE MARKER IN ENZYME-IMMUNOASSAYS
Grassi J., Pradelles P. Compounds labelled by the acetylcholinesterase of Electrophorus Electricus. Its preparation process and its use as a tracer or marquer in enzymo-immunological determinations. United States patent, N° 1,047,330. September 10, 1991
Grassi J., Pradelles P. The use of Acetylcholinesterase as a Universal marker in Enzyme-Immunoassays. Proceedings of the Third International Meeting on Cholinesterases, American Chemical Society (1991)
Pradelles P., Grassi J., Maclouf J. Enzyme Immunoassays of Eicosanoids Using Acetylcholinesterase. Methods in Enzymology (1990), vol. 187, 24-34
PRODUCT EXPLANATION : QRFP26-RFa
Chartrel N., Alonzeau J. Alexandre D. et al. The RFamide neuropeptide QRFP-26RFa and its role in the control of neuroendocrine functions. Frontiers in Neuroendocrinology 32 (2011) 387–397
Thuau R., Guilhaudis L., Ségalas-Milazzo I. et al. Structural studies on QRFP-26RFa, a novel human RFamiderelated peptide with orexigenic activity. Peptides 26 (2005) 779–789
Jiang FY., Luo L., Gustafson EL. et al. Identifi cation and characterization of a novel RF-amide peptide ligand for orphan G-protein-coupled receptor SP9155. J. Biol. Chem.278 (2003) 27652–27657
Bruzzone F., Lectez B., Tollemer H. et al. Anatomical distribution and biochemical characterization of the novel RFamide peptide QRFP-26RFa in the human hypothalamus and spinal cord. J. Neurochem. 99 (2006) 616–627
Takayasu S., Sakurai T., Iwasaki S. et al. Neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice. Proc. Natl. Acad. Sci.USA 103 (2006) 7438–7443
Egido E.M., Hernández R., Leprince J. et al. QRFP-26RFa, a novel orexigenic neuropeptide, inhibits insulin secretion in the rat pancreas. Peptides 28 (2007) 725–730
Prévost G., Jeandel L., Arabo A. et al. Hypothalamic Neuropeptide 26RFa Acts as an Incretin to Regulate Glucose Homeostasis. Diabetes 2015;64:2805–2816
DOI: 10.2337/db14-1864
Mulumba M., Jossart C., Granata R. et al. GPR103b functions in the peripheral regulation of adipogenesis. Mol. Endocrinol. 24 (2010) 1615–1625
Chen A., Chiu C N., Mosser E A. et al. QRFP and Its Receptors Regulate Locomotor Activity and Sleep in Zebrafish. The Journal of Neuroscience. 2016 February 10, 36(6):1823–1840
PRODUCT EXPLANATION: KIT DEVELOPMENT
Valentin MA, Ma S, Zhao A, Legay F, Avrameas A. Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies. J Pharm Biomed Anal. (2011) 55(5): 869-877
European Medicines Agency. Guideline on bioanalytical method validation, 21 July 2011